Modified Bell staging criteria for NEC Stage Classification Systemic signs Intestinal signs Radiologic signs

We studied the occurrence of necrotizing enterocolitis in 2681 very low birth weight infants during an 18-month period to characterize the biodemographic and clinical correlates. Proven necrotizing enterocolitis (Bell stage II and beyond) occurred in 10.1% of study infants; necrotlzing enterocolitis was suspected in 17.2% of study infants. Positivity of b lood cultures was related to necrotizing enterocolitis staging. The mortality rate increased only for stage III necrotizing enterocolitls (54% died). Logistic regression identified medical center of birth, race, gender, birth weight, maternal hemorrhage, duration of ruptured membranes, and cesarean section as significant risk factors. For one center the odds ratio was 3.7, whereas for another center it was only 0.3. For black boys, the odds ratio was 2.3 relative to nonblack boys; for girls, race did not affect prevalence of necrotizing enterocolitis. Age at onset was related to birth weight and gestational age. Intercenter differences in necrotizing entero. colitis prevalence were related to time required to regain birth weight and other indicators of fluid management. Gram-positive organisms predominated in positive blood cultures for stage I and II necrotizing enterocolitis; enteric bacteria were isolated more frequently in infants with stage Ill disease. We conclude that necrotizing enterocolitis prevalence varies greatly among centers; this may be related to early clinical practices of neonatal care. (J PEDIATR 1991;119: 630-8)

[1]  R. Platt,et al.  Association of intravenous lipid emulsion and coagulase‐negative staphylococcal bacteremia in neonatal intensive care units , 1991, The New England journal of medicine.

[2]  M. Miller,et al.  Intraluminal pathogenesis of necrotizing enterocolitis. , 1990, The Journal of pediatrics.

[3]  J. Halac,et al.  Prenatal and postnatal corticosteroid therapy to prevent neonatal necrotizing enterocolitis: a controlled trial. , 1990, The Journal of pediatrics.

[4]  R. Kliegman Models of the pathogenesis of necrotizing enterocolitis , 1990, The Journal of Pediatrics.

[5]  M. Caplan,et al.  Role of platelet activating factor and tumor necrosis factor-alpha in neonatal necrotizing enterocolitis. , 1990, The Journal of pediatrics.

[6]  C. C. Patrick Coagulase-negative staphylococci: pathogens with increasing clinical significance. , 1990, The Journal of pediatrics.

[7]  R. Romero,et al.  Detection of platelet-activating factor in amniotic fluid of complicated pregnancies. , 1990, American journal of obstetrics and gynecology.

[8]  I. Chalmers,et al.  The effects of corticosteroid administration before preterm delivery: an overview of the evidence from controlled trials , 1990, British journal of obstetrics and gynaecology.

[9]  P. Gimotty,et al.  Factors Associated with Age of Onset of Necrotizing Enterocolitis , 1989, American journal of perinatology.

[10]  J. Sinclair,et al.  An analysis of birth weight by gestational age in Canada. , 1989, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne.

[11]  R. Holman,et al.  Necrotizing enterocolitis mortality in the United States, 1979-85. , 1989, American journal of public health.

[12]  W. Hsueh,et al.  Bowel necrosis induced by tumor necrosis factor in rats is mediated by platelet-activating factor. , 1988, The Journal of clinical investigation.

[13]  R. Dyer,et al.  Delta-like toxin produced by coagulase-negative staphylococci is associated with neonatal necrotizing enterocolitis , 1987, Infection and immunity.

[14]  M. Curtis,et al.  A case control study of necrotizing enterocolitis occurring over 8 years in a neonatal intensive care unit , 1987, European Journal of Pediatrics.

[15]  T. Putnam,et al.  Evaluation of factors in high risk neonatal necrotizing enterocolitis. , 1987, Journal of pediatric surgery.

[16]  A. Robertson,et al.  The Effect of Hydrocortisone, Thyroxine, and Phenobarbital on Diamine Oxidase Activity in Newborn Rat Intestine , 1987, Pediatric Research.

[17]  G. Peckham,et al.  Perinatal events and necrotizing enterocolitis in premature infants , 1987, American journal of diseases of children.

[18]  J. D. Albert,et al.  Shock and tissue injury induced by recombinant human cachectin. , 1986, Science.

[19]  G. Hutchins,et al.  Risk Factors for Developing and Dying from Necrotizing Enterocolitis , 1986, Journal of pediatric gastroenterology and nutrition.

[20]  Robert M. Kliegman,et al.  Necrotizing Enterocolitis: Treatment Based on Staging Criteria , 1986, Pediatric Clinics of North America.

[21]  F. Bowen,et al.  Relationship of prolonged pharmacologic serum levels of vitamin E to incidence of sepsis and necrotizing enterocolitis in infants with birth weight 1,500 grams or less. , 1985, Pediatrics.

[22]  W. Poole,et al.  A decreased incidence of necrotizing enterocolitis after prenatal glucocorticoid therapy. , 1984, Pediatrics.

[23]  R. Ryder,et al.  Necrotizing enterocolitis: a prospective multicenter investigation. , 1980, American journal of epidemiology.

[24]  A. Y. Sweet,et al.  Preventing necrotizing enterocolitis in neonates. , 1978, JAMA.

[25]  M. J. Bell,et al.  Neonatal Necrotizing Enterocolitis: Therapeutic Decisions Based upon Clinical Staging , 1978, Annals of surgery.

[26]  W. Berdon,et al.  Acute necrotizing enterocolitis in infancy: a review of 64 cases. , 1975, Pediatrics.

[27]  K. Gergely,et al.  Necrotizing enterocolitis of premature infants. , 1970, Surgery.

[28]  N. Kretchmer,et al.  Intestinal Invertase: Precocious Development of Activity after Injection of Hydrocortisone , 1964, Science.

[29]  J. Neu,et al.  Glucocorticoid-Mediated Alteration of Fluidity of Brush Border Membrane in Rat Small Intestine , 1986, Pediatric Research.